Cite
Bertrums EJM, Zwaan CM, Hasegawa D, et al. Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS. Haematologica. 2021;doi: 10.3324/haematol.2021.279507.
Bertrums, E. J. M., Zwaan, C. M., Hasegawa, D., De Haas, V., Reinhardt, D. N., Locatelli, F., De Moerloose, B., Dworzak, M., Buijs, A., Smisek, P., Kolenova, A., Pronk, C. J., Klusmann, J. H., Carboné, A., Ferster, A., Antoniou, E., Meshinchi, S., Raimondi, S. C., Niemeyer, C. M., Hasle, H., Van den Heuvel-Eibrink, M. M., & Goemans, B. F. (2021). Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS. Haematologica, . https://doi.org/10.3324/haematol.2021.279507
Bertrums, Eline J M, et al. "Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS." Haematologica vol. (2021). doi: https://doi.org/10.3324/haematol.2021.279507
Bertrums EJM, Zwaan CM, Hasegawa D, De Haas V, Reinhardt DN, Locatelli F, De Moerloose B, Dworzak M, Buijs A, Smisek P, Kolenova A, Pronk CJ, Klusmann JH, Carboné A, Ferster A, Antoniou E, Meshinchi S, Raimondi SC, Niemeyer CM, Hasle H, Van den Heuvel-Eibrink MM, Goemans BF. Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS. Haematologica. 2021 Dec 02; doi: 10.3324/haematol.2021.279507. Epub 2021 Dec 02. PMID: 34854279.
Copy
Download .nbib